Comparison

BMS-690514 European Partner

Item no. HY-10333-50mg
Manufacturer MedChem Express
CASRN 859853-30-8
Amount 50 mg
Quantity options 10mM/1mL 10 mg 2 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.07
Formula C19H24N6O2
Citations [1]Wong TW, et al. Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase families. Clin Cancer Res. 2011 Jun 15;17(12):4031-41.<br/>[2]Marathe P, et al. Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2. J Pharm Sci. 2010 Aug;99(8):3579-93.
Smiles O[C@@H]1CN(CC[C@H]1N)CC2=C3C(NC4=CC=CC(OC)=C4)=NC=NN3C=C2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 859853-30-8
Available
Product Description
BMS-690514 is a potent and orally active inhibitor of EGFR and VEGFR; has IC50s of 5, 20 and 60 nM for EGFR, HER 2 and HER 4, respectively.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
368.43
Clinical Information
Phase 2
Manufacturers Research Area
Cancer; Cardiovascular Disease
Solubility
DMSO : ≥ 25 mg/mL
Target
EGFR; VEGFR
Manufacturers Target
EGFR; VEGFR
Isoform
EGFR/ErbB1/HER1; ErbB2/HER2; ErbB4/HER4
Manufacturers Pathway
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close